1st Quarter - Report

AMGEN, INC. for AMGEN INC

Firm
Client
Income
—
Expenses
$3,310,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Market Access and Intellectual Property (no specific bill)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

International tax issues, including: H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 Puerto Rico Tax Incentives

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
NANCY ELLEN MCCARTHY —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); SENATE

Bills named: H.R. 1 (115th)

Copyright/Patent/Trademark CPT

S. 974 CREATES Act of 2017 S. 124 Preserve Access to Affordable Generics Act Issues related to drug patents and exclusivities (no bill)

LobbyistCovered position, as disclosed
L NICOLE CURRIE —
REBECCA MANDELL —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); SENATE; Office of Management & Budget (OMB)

Bills named: S. 974 (115th), S. 124 (115th)

Health Issues HCR

Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill H.R. 695 Department of Defense Appropriations Act

Contacted: Executive Office of the President (EOP); Office of Management & Budget (OMB); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Bills named: S.Con.Res. 3 (115th), H.R. 1245 (115th), H.R. 695 (115th), S. 469 (115th), S. 2042 (115th)

Medicare/Medicaid MMM

Medicare Part B (Average Sales Price) Medicare Part D rebates Coding and reimbursement for oncology drugs/biologics/biosimilars H.R. 1982 Bipartisan Budget Act of 2018 (issues related to Medicare Part D coverage gap) H.R. 849 Protecting Seniors' Access to Medicare Act of 2017 (issues related to IPAB) 340B Protecting Access for the Underserved and Safety-Net Entities H.R. 1625 Consolidated Appropriations Act, 2018 (biosimilars) (Medicare Part D coverage gap) H.R. 1892 Further Extension of Continuing Appropriations Act (biosimilars)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
RUTH HOFFMAN —
JESSE KERNS —
REBECCA MANDELL —
HOWARD MOON —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Commerce, Dept of (DOC)

Bills named: H.R. 1982 (115th), H.R. 1892 (115th), H.R. 1625 (115th), H.R. 849 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.